Telix to Host Investor Day in New York City on June 11, 2025

Melbourne (Australia) and Indianapolis, IN (U.S.) | 22 May 2025

Telix today announces it will host an Investor Day on Wednesday, June 11, 2025, in person, in New York City, from 8:30am to 12.30pm ET.

Institutional investors, analysts and company guests are cordially invited to attend the session, which will focus on the growth opportunities across Telix’s commercial and clinical portfolio of precision medicine and therapeutic radiopharmaceuticals.

Members of the Telix leadership team will present at the event, including Managing Director and Group CEO, Dr. Christian Behrenbruch; Group Chief Medical Officer, Dr. David N. Cade; CEO Therapeutics, Mr. Richard Valeix and CEO Precision Medicine, Mr. Kevin Richardson.

Key Opinion Leaders will also provide their perspectives on the clinical utility and opportunity for Telix’s theranostic candidates.

Advance registration is required for this event. Please RSVP by sending an email to annie.kasparian@telixpharma.com.

Note: This event is for qualified institutional investors and analysts.